In a new filing with the U.S. Securities and Exchange Commission, Elliott Management , led by Paul Singer , disclosed increasing its activist position in CorMedix Inc. . The stake was raised to 2.37 million shares from 1.50 million shares that Elliott Management held at the end of the first quarter of 2015.
↧